NCT07225270
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07225270
Title Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy (RAINFOL-04)
Acronym RAINFOL-04
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mt. Sinai Comprehensive Cancer Center RECRUITING Miami Florida 33140 United States Details
Osaka Medical and Pharmaceutical University Hospital RECRUITING Takatsuki Osaka Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field